- What is Solanezumab for?
- How Solanezumab works
- See other forms of treatment that may be useful to improve the quality of life of Alzheimer's patients at:
Solanezumab is a drug capable of stopping the development of Alzheimer's disease, as it prevents the formation of protein plaques that form in the brain, which are responsible for the onset of the disease and which causes symptoms such as memory loss, disorientation and difficulty in speaking, for example. Find out more about the disease at: Alzheimer's symptoms.
Although this medicine is not yet on sale, it is being developed by the pharmaceutical company Eli Lilly & Co and it is known that the sooner you start taking it the better the results can be, contributing to the patient's quality of life with this insanity.
What is Solanezumab for?
Solanezumab is a medication that fights dementia and serves to stop the development of Alzheimer's disease in the initial stage, which is when the patient has few symptoms.
Thus, Solanezumab helps the patient to preserve memory and does not develop symptoms as quickly as disorientation, inability to identify the function of objects or difficulty in speaking, for example.
How Solanezumab works
This medication prevents the development of protein plaques that form in the brain and are responsible for the development of Alzheimer's disease, acting on the beta-amyloid plaques, which accumulate in the neurons of the hippocampus and the basal nucleus of Meyenert.
Solanezumab is a medication that must be indicated by the psychiatrist, and tests indicate that at least 400 mg should be taken through an injection into the vein for about 7 months.
See other forms of treatment that may be useful to improve the quality of life of Alzheimer's patients at:
